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Abstract 
BACKGROUND: Smokeless tobacco products due to their high nicotine content are highly addictive and 
ultimately lead to an increased risk of oral cavity, laryngeal and oesophagal cancer.  
AIM: This research was conducted with the aim of assessing the relationship between the salivary cotinine 
concentration and demographic characteristics and smokeless tobacco use for the first time in tradespeople in 
Chabahar, Iran. 
METHODS: This descriptive cross-sectional study was conducted on 150 different tradespeople using smokeless 
tobacco in Chabahar who were selected through simple random sampling in 2018. In addition to the salivary 
cotinine measurement, data were collected using a researcher-made questionnaire with demographic and 
behavioural items. The data obtained were analysed in SPSS-16 using descriptive and inferential statistics. 
RESULTS: The mean salivary cotinine score was 887.7 ± 180.7 in men and 611.2 ± 139.7 in women, making for 
a significant intergroup difference (P = 0.043). The mean salivary cotinine score was higher in those who used 
two or more smokeless tobacco products compared to those who used one type of tobacco, and a significant 
difference was observed between the type of smokeless tobacco used and the salivary cotinine score in the 
participants (P = 0.005).  
CONCLUSION: Based on the results of the regression analysis, the type of smokeless tobacco used was a 
strong predictor of the concentration of salivary cotinine in the participants. It is, therefore, necessary for the 
government to adopt appropriate policies and take educational measures to reduce the vending and use of these 
substances. 
 
 
 
Introduction 
 
Almost one-fifth of the tobacco used in the 
world is smokeless form [1]. Smokeless tobacco 
products are highly addictive due to their high nicotine 
content [2]. These products also contain carcinogenic 
compounds such as Tobacco-Specific N-nitrosamines 
(TSNAs), which eventually lead to an increased risk of 
oral cavity, laryngeal and oesophagal cancer [3]. An 
increased risk of mortality due to cardiovascular 
diseases has also been observed among smokeless 
tobacco users [3]. Around 10 million people are 
estimated to die of tobacco use in developing 
countries by 2030, and this figure is higher than the 
figures estimated for AIDS, drug abuse, road 
accidents, murder and suicide [4]. 
There are wide ranges of smokeless tobacco 
products throughout the world [5]. Naswar, Gutka, 
Pan Parag, BT and Mawa are some of the common 
smokeless tobacco products among tradespeople in 
Chabahar [6]. All brands of smokeless tobacco that 
are sold for oral or nasal-use have nicotine and 
nitrosamines as ingredients [7]. Also, smokeless 
tobacco components consist of tobacco, areca nut, 
slaked lime, and spices [8]. The proximity of Chabahar 
to Pakistan and the illicit import of various smokeless 
tobacco products in attractive packaging has led to 
the wide availability of these products in the market 
and stores around this city [9]. The poor knowledge of 
tradespeople about nature and side-effects and ease 
of access to these substances have led to their 
increased use [9]. The nicotine content of a 
smokeless tobacco product may vary depending on its 
type [10]. The measurement of nicotine and its 
metabolite in smokeless tobacco users is therefore 
important for understanding its addictive potential [10]. 
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Cotinine is a sensitive and special quantitative index 
for learning of the amount of nicotine absorption over 
the preceding few days [10]. This concentration is 
assessed by the rate of nicotine metabolism in body 
fluids [11], [12]. Saliva currently provides an 
appropriate diagnostic alternative to other body fluids, 
as it offers a cost-effective, simple and non-invasive 
method that does not require any particular expertise 
for sample collection [13], [14].  
Very few studies have investigated the 
relationship between cotinine concentration and 
smokeless tobacco use behaviour in the users of 
these products [3], [13], [15].  
The present study was therefore conducted to 
examine the relationship of salivary cotinine 
concentration with demographic details and 
smokeless tobacco use behaviour among 
tradespeople in Chabahar. 
 
 
Methods 
 
The present descriptive cross-sectional study 
was conducted in Chabahar, Iran, in 2018. After 
obtaining permission from the university ethics 
committee, 150 different tradespeople in Chabahar 
entered the study with informed consent. The study 
inclusion criteria consisted of using at least one type 
of smokeless tobacco, age 20 to 50 years, the ability 
to answer the questionnaire items and a trading 
license from the Guilds Office. The exclusion criteria 
consisted of age less than 20 or above 50 years, 
smoking cigarettes, hookah, etc., and being a 
seasonal tradesman. Simple random sampling was 
used in the study. To this end, the environmental and 
occupational health division of the health centre was 
visited and using the health records, a list of 
participants was extracted from 18 urban and rural 
comprehensive health service centres, and those 
eligible for inclusion in the study were selected 
through simple random sampling. In addition to 
measuring the salivary cotinine, data were also 
collected using a researcher-made questionnaire in 
two parts, including a part on demographic details and 
some behavioural items. The demographic 
questionnaire contained seven items, including age, 
gender, type of trade, education, marital status, use of 
smokeless tobacco among family members and use 
of smokeless tobacco among friends and peers. 
Behaviour questionnaire contained five items, 
including the type of smokeless tobacco used, age at 
the onset of use, the daily frequency of use, the saliva 
disposal method and the use of tobacco in public 
places. 
The amounts of salivary cotinine in the 150 
participants were assessed using the ELISA method 
and the US-made Salimetrics kit (LOT: 1710502, 
EXP: 2019-07-11). With the help of some facilitators, 
the researcher collected participants’ saliva samples 
by spitting method. For this purpose, the candidates 
were asked to visit the center in a fasting state from 
one hour before the test and to refrain from alcohol 
consumption 12 hours before the test and to rinse 
their mouth properly before the test samples were to 
be taken (for 10 minutes), and then spit into a test 
tube via a glass funnel for at least five minutes. At 
least 5 ml of saliva were collected from each 
candidate, and the samples were delivered to the 
laboratory of the comprehensive health service centre 
of Polan (a village in Chabahar County) with the cold 
chain maintained and daily. At the laboratory, the 
salivary samples were frozen at -20°C in an ultra-low 
temperature freezer. Finally, after these steps were 
over, all the samples were tested together according 
to the kit's specific instructions. 
The data obtained from the questionnaire 
were analyzed in SPSS-16 using descriptive statistics 
(frequency, mean and standard deviation) and 
inferential statistics (the Kolmogorov-Smirnov test for 
assessing the normality of the distribution of salivary 
cotinine, the ANOVA and independent t-test for 
assessing the relationship of the salivary cotinine 
concentration with the demographic variables and use 
behaviors, and the regression analysis for predicting 
the concentration of salivary cotinine through the 
variables related to tobacco use). The level of 
statistical significance was set at P < 0.05. 
 
 
Results 
 
The majority of the participants were male 
(59.3%), and Most of them were in the 20-30 age 
group (66.7%). The use of at least one type of 
smokeless tobacco was reported as 11.3% among the 
family members and 81.3% among close friends 
(Table 1).  
Table 1: Participants' demographic details 
Variable Count Percentage 
Age (years) 
20-30 100 66.7 
30-40 40 26.7 
40-50 10 6.6 
Gender 
Male 89 59.3 
Female 61 40.7 
Marital status 
Single 55 36.7 
Married 95 63.3 
Trade type 
Confectionery 7 4.7 
Drapery 22 14.7 
Supermarket 20 13.3 
Auto repair 17 11.3 
Hairdressing 35 23.3 
Dressmaking and embroidery 9 6 
Wholesale 22 14.6 
Other (hoteling, restaurant, 
carpentry, etc.) 
18 12 
Education 
Illiterate 19 12.7 
Primary School 25 16.7 
Junior High School 23 15.3 
High School and Above 83 55.3 
Use of one type of 
smokeless tobacco 
products among family 
members 
Yes 17 11.3 
No 133 88.7 
Use of one type of 
smokeless tobacco 
products among five close 
friends 
Yes 122 81.3 
No 28 18.7 
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Dividing the results by gender, Naswar was 
the most frequent type of smokeless tobacco used by 
the participating women (83.6%), but most of the 
participating men (67.42%) used a combination of two 
or more smokeless tobacco products. A significant 
relationship was found between the type of smokeless 
tobacco used and gender (P = 0.000). Dividing the 
results by age at the onset of use, approximately 86% 
of the participating men and women had started 
tobacco use before and after the age of ten. A 
significant relationship was also observed between 
age at the onset of use and gender (P = 0.000). 
Concerning the frequency of use, the majority of the 
participants (53.33%) used these products more than 
five times per day. Overall, 70% of the participants 
spit their saliva into public pathways in an unhygienic 
manner after consumption. Furthermore, the majority 
of the participants (62%) used these products in public 
places. A significant relationship was also found 
between this variable and gender (P = 0.007) in this 
study (Table 2). 
Table 2: Participants' smokeless tobacco use behaviour 
Tobacco Use Behavior Total 
Count 
(percentage) 
Male Count 
(Percentage) 
Female Count 
(Percentage) 
P-Value 
0.000 
Type of 
smokeless 
tobacco 
Pan Parag 2 (1.33) 2 (2.24) 0 
Gutka 19 (12.66) 11 (12.36 8 (13.12) 
Naswar 66 (45) 15 (16.86) 51 (83.6) 
Mawa 1 (0.66) 1 (1.12) 0 
A combination of two or more 62 (41.34) 60 (67.42) 2 (3.28) 
Age at the 
onset of use 
Below 10 85 (56.67) 77 (86.52) 8 (13.11) 0.000 
Above 10 65 (43.33) 12 (13.48) 53 (86.89) 
Frequency of 
daily use 
Less than 5 times 70 (46.67) 41 (46.07) 29 (47.54) 0.869 
5 times and more 80 (53.33) 48 (53.93) 32 (52.46) 
Disposal of 
saliva 
Hygienic 105 (70) 63 (70.79) 42 (68.85) 0.857 
Unhygienic 45 (30) 26 (29.21) 19 (31.15) 
Use of 
tobacco in 
public places 
Yes 93 (62) 63 (70.79) 30 (49.18) 0.007 
No 57 (38) 26 (29.21) 31 (50.82) 
 
The mean score of salivary cotinine was 
666.5 ± 119.3 ng/ml in the 30-40 age group, which is 
higher than that in the other age groups. No significant 
relationship was observed between the salivary 
cotinine score and age group (P = 0.295). The mean 
salivary cotinine score was 887.7 ± 180.7 ng/ml in the 
women and 611.2 ± 139.7 ng/ml in the men, which 
makes for a significant difference (P = 0.043). In terms 
of marital status, the mean salivary cotinine score was 
higher in the single than the married participants, 
although not significantly (P = 0.69). The mean 
salivary cotinine score was the highest in the auto 
repair business, but the difference was not significant 
(P = 0.1) between the various businesses (Table 3). 
Table 3: The relationship between the demographic variables 
and the concentration of salivary cotinine in smokeless 
tobacco users 
Variable Cotinine (ng/ml) df F P-Value 
Mean SD 
Age (years) 20-30 666.5 119.3 2 1.23 0.295 
30-40 831.5 18.5 
40-50 112.2 22.7 
Gender Male 887.7 180.7 148 3.26 0.043 
Female 611.2 139.7 
Marital status Single 1073.0 132.5 148 0.78 0.69 
Married 642.0 364.0 
Trade type Confectionery 310.5 150.5 9 1.66 0.1 
Drapery 642.0 364.0 
Supermarket 831.5 18.5 
Auto repair 887.7 180.7 
Hairdressing 660.0 118.3 
Dressmaking and embroidery 333.5 220.5 
Wholesale 22.5 528.7 
Other (hoteling, restaurant, 
carpentry, etc.) 
370.6 220.5 
The mean salivary cotinine score was 1068.5 
± 131.2 ng/ml in the participants who used two or 
more smokeless tobacco products, which is higher 
than in those who used other forms of tobacco and a 
significant difference was thus observed between the 
type of smokeless tobacco used and the salivary 
cotinine score (P = 0.005). The mean salivary cotinine 
score was higher in the participants who had started 
using smokeless tobacco before the age of ten (760.0 
± 207.6 ng/ml), but no significant relationship was 
observed between age at the onset of use and the 
mean salivary cotinine score (P = 0.746). The mean 
salivary cotinine score was lower in those who had 
reported their frequency of use as less than five times 
per day compared to those who had reported their 
daily use like 5 times and more; however, the 
difference between these variables was not significant 
(P = 0.776; Table 4). 
Table 4: The relationship between tobacco use behaviours and 
the concentration of salivary cotinine in smokeless tobacco 
users 
Variable Cotinine (ng/ml) df F P-Value 
Mean SD 
Type of 
smokeless 
tobacco 
Pan Parag 703.5 73.5 4 3.9
3 
0.005 
Gutka 501.0 18.5 
Naswar 627.0 160.3 
Mawa 4.0 18.0 
A combination of two or more 1068.5 131.2 
Age at the 
onset of 
use 
Below 10 760.0 207.6 148 1.3
3 
0.746 
Above 10 719.3 72.2 
Frequency 
of daily use 
Less than 5 times 790.0 42.8 148 0.1
18 
0.776 
5 times and more 662.0 133.3 
 
The results of the regression analysis showed 
that, of the six subscales (gender, trade type, marital 
status, type of smokeless tobacco used, age at the 
onset of use and daily frequency of use), only one 
subscale (type of smokeless tobacco used) predicted 
the concentration of salivary cotinine significantly (P = 
0.001); that is, with every standard deviation of 
increase in the score of the type of smokeless tobacco 
used, the score of the concentration of salivary 
cotinine increased by 0.66 standard deviations (Table 
5).  
Table 5: The prediction of salivary cotinine concentration 
through the demographic variables and tobacco use behaviour 
using the multivariate regression analysis 
Predictor 
Variable 
B SE Beta T P-value 
Constant -47.7 246.1 - -0.19 0.84 
Gender 97.4 90.9 0.13 1.07 0.28 
Trade type 6.3 10.4 0.05 0.6 0.54 
Marital status -30.9 57.9 -0.04 -0.53 0.59 
Type of 
smokeless 
tobacco used 
98.4 27.9 0.33 3.53 0.001 
Age at the 
onset of use 
-9.3 81.7 0.01 -0.11 0.9 
Frequency of 
daily use 
45.2 56.1 0.06 0.8 42 
  
 
Discussion 
The present study was conducted to assess 
the relationship of the concentration of salivary 
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cotinine with demographic variables and smokeless 
tobacco use behaviours for the first time among 
tradespeople in Chabahar. Another exclusive feature 
of the study is that it assessed all types of smokeless 
tobacco products commonly used in Chabahar. The 
results obtained showed that auto repair businesses 
had the highest mean salivary cotinine score (888 ± 
181ng/ml), while the confectionery trade had the 
lowest score (311 ± 151 ng/ml); however, the 
difference between the businesses was not significant 
in this respect (P > 0.005). In a study conducted by 
Ferketich et al., [16], the mean salivary cotinine score 
was 581 ± 364 ng/ml in full-time workers and 389 ± 
264 ng/ml in part-time workers.  
In this study, the mean salivary cotinine score 
was very high in both men and women (749.5ng/ml) 
compared to the other studies on the subject [15], 
[16], [17], [18], [19].  
According to the results, the mean salivary 
cotinine score was higher in the participants who used 
two or more types of smokeless tobacco products 
compared to those who used only one type, and a 
significant relationship was observed between the 
type of smokeless tobacco used and the salivary 
cotinine score (P < 0.005). Naswar was the most 
commonly-used type of smokeless tobacco (84%) by 
the women, while the men most commonly used a 
combination of two or more different types (67%). One 
of the reasons for this difference between the genders 
could be the social norms of the society under 
scrutiny, as women’s use of other types of smokeless 
tobacco products (such as Pan Parag, Gutka, Mawa, 
BT, etc.) is not acceptable in the cultural fabric of the 
society. The mean salivary cotinine score in people 
who used two or more different types of smokeless 
tobacco was lower in other studies compared to in the 
present study –revealing an inconsistency between 
findings [3], [16], [20]. 
The mean salivary cotinine score was higher 
in those who had started using smokeless tobacco 
before the age of ten compared to those who had 
started after the age of ten (760 ± 208 ng/ml vs 719 ± 
72 ng/ml), but there were no significant relationships 
between the age at the onset of use and the mean 
salivary cotinine score (P > 0.005). In other words, 
those who had started using smokeless tobacco from 
a long time ago had a higher mean salivary cotinine 
score. The longer duration of use might affect the 
salivary cotinine concentration in people who use 
these products. In the study by Ferketich et al., [16], 
the mean salivary cotinine score in people who had 
started using smokeless tobacco before the age of ten 
was 610 ± 387 ng/ml, which is less than that found in 
the present study. 
According to the present findings, the mean 
salivary cotinine score was higher in people whose 
daily use of smokeless tobacco products was less 
than five times compared to in those who used these 
products more than five times per day (790 ± 43 ng/ml 
vs 662 ± 133 ng/ml), but the difference between these 
variables was not significant (P > 0.005). In 
Ferketich’s study [16], the mean salivary cotinine 
score was higher in those whose daily use of 
smokeless tobacco was more than 48 times 
compared to those whose daily use was less (620 ± 
400 ng/ml vs. 483 ± 321 ng/ml), which disagrees with 
the present findings in this regard. This disparity of 
findings could be due to the self-reporting nature of 
that study (i.e. false reports of the frequency of use), 
which is often one of the main challenges in research 
in various fields of science. 
The mean salivary cotinine score was 888 ± 
181 ng/ml in men and 611 ± 140 ng/ml in women, 
which suggests a significant difference between the 
genders (P < 0.005). One of the reasons for this 
difference could be the type of product used by the 
two genders. The most commonly-used product in 
women was Naswar (84%), while most of the men 
used a combination of two or more products (67%), 
which explains the much higher concentration of 
salivary cotinine in men (who used two or more types 
of smokeless tobacco products) compared to women 
(who only used Naswar) in the present study. In a 
study conducted by Huque et al., [3], the mean 
salivary cotinine score was 399 ng/ml in men and 361 
ng/ml in women, which shows no significant 
differences between the genders in terms of the 
concentration of salivary cotinine, as inconsistent with 
the present findings. The results obtained by Asha et 
al., [21], however, nearly agree with the present 
findings. 
In the present study, the mean salivary 
cotinine score was higher in the single compared to 
the married participants (1073 ± 133 ng/ml vs 642 ± 
364 ng/ml); however, the difference between the two 
groups was not significant (P > 0.005). In Ferketich’s 
study [16], the mean salivary cotinine score was 364 ± 
254 ng/ml in the single and 562 ± 319 ng/ml in the 
married people, which disagrees with the present 
findings, since it shows a higher mean concentration 
of salivary cotinine in the married compared to the 
single people and also a significant relationship 
between marital status and the concentration of 
salivary cotinine. In a study conducted by Binnie et al., 
[22], the mean salivary cotinine score was higher in 
the married compared to the single people, which 
disagrees with the present findings. The disparity of 
findings between the present study and the two cited 
studies could be due to the false reports of marital 
status or type of tobacco products used.  
The results of the regression analysis in the 
present study showed that, out of the six subscales of 
demographic variables and tobacco use behaviors, 
only one subscale, i.e. the type of smokeless tobacco 
used, predicted the concentration of salivary cotinine 
significantly (P < 0.001); that is, with every standard 
deviation of increase in the score of the type of 
smokeless tobacco used, the salivary cotinine 
concentration score increased by 0.66 standard 
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deviations. In the other studies, too, this variable could 
predict the concentration of salivary cotinine in the 
participants [3], [16]. In a study conducted by Lorina et 
al., [20], subscales including age, the frequency of 
daily use and age at the onset of use predicted the 
concentration of salivary cotinine in tobacco users. 
One of the limitations of this study is the self-
report nature of data collection about smokeless 
tobacco use behaviours, such as the frequency of 
use, age at the onset of use, type of smokeless 
tobacco used, etc. 
In conclusion, according to the results of the 
regression analysis, the type of smokeless tobacco 
used is a strong predictor of the concentration of 
salivary cotinine. It is, therefore, necessary for the 
government to adopt appropriate policies and 
educational measures to reduce the vending and use 
of these substances. Similar studies are 
recommended to be conducted with larger sample 
sizes on other groups of the users of these products.  
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